Curaleaf Holdings Inc
Change company Symbol lookup
Select an option...
CURLF Curaleaf Holdings Inc
EPRT Essential Properties Realty Trust Inc
CRIS Curis Inc
PIXY ShiftPixy Inc
RVLP RVL Pharmaceuticals PLC
NAUT Nautilus Biotechnology Inc
BOF BranchOut Food Inc
SPRC Scisparc Ltd
NRSN Neurosense Therapeutics Ltd
ACNT Ascent Industries Co
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Curaleaf Holdings, Inc. is a Canada-based international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. It operates in approximately 19 states and owns and operates 152 dispensaries and 22 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: Vape Oils & Concentrates, Flower, Prerolls & Flower Pods, Topical Lotions, Capsules & Tinctures, Mints & Lozenges and Edibles.

Closing Price
$4.52
Day's Change
0.028 (0.62%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.60
Day's Low
4.20
Volume
(Light)
Volume:
563,464

10-day average volume:
1,329,748
563,464

Display:

Providers:

UpdateCancel
All providers
Yesterday's News, September 28, 2023
Cannabis company Curaleaf applying to move listing to Toronto Stock Exchange in a move to boost visibility

By Steve Gelsi Curaleaf Chairman Boris Jordan takes aim at a potential Toronto Stock Exchange listing after the company completes a capital raise to fulfill a TSX requirement (MarketWatch)

Inside the Best-Performing ETF of Q3

Roundhill Cannabis ETF (WEED) topped the list of the best-performing ETFs of the third quarter with impressive returns of about 49%. (Zacks)

September 27, 2023
Curaleaf Announces Proposed Offering of Subordinate Voting Shares

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, announced...(PR Newswire)

Cannabis stocks rise as Senate committee OKs cannabis banking bill

By Steve Gelsi The bill to open up the financial system to legal cannabis companies now heads to the full Senate for a vote Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs...(MarketWatch)

September 18, 2023
Cannabis Stocks & ETFs: Can the Recent Surge Continue?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.(Zacks)

September 15, 2023
Canopy Growth's stock sustains rally as it draws praise for BioSteel exit

By Steve Gelsi Canadian cannabis company Canopy Growth adds another double-digit percentage gains as cannabis stocks gain traction Canopy Growth Corp.'s stock was rallying by about 12% on Friday to finish out an eventful week for the...(MarketWatch)

Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27

By Victor Reklaitis Marijuana stocks trade sharply higher Friday The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work...(MarketWatch)

September 12, 2023
New York State opens up cannabis license process

The New York State Cannabis Control Board on Tuesday voted to open up the application process starting next month for businesses seeking to sell, grow, process and distribute marijuana for adult use. Companies with an existing presence in the...(MarketWatch)

Canopy Growth's stock falls back from recent gains as cannabis stocks cool off

By Steve Gelsi Pot stocks fall back but manage to hold on to most of their recent gains, for now Canopy Growth Corp.'s stock fell about 14% on Tuesday after it more than doubled in the two previous days, as the sector pivoted away...(MarketWatch)

September 11, 2023
Canopy Growth's stock rockets to a record rally, has quadrupled in two weeks

By Steve Gelsi Cannabis company's climbs more than 80% to the first close above $1 in 4 months Shares of Canopy Growth Corp. continued their rocket ride Monday to break above the $1 level for the first time since May, as cannabis...(MarketWatch)

September 07, 2023
Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging

By Victor Reklaitis Leaders of the Republican-run House are 'either agnostic or opposed' to the bill, analyst says Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely...(MarketWatch)

September 06, 2023
Medical-cannabis companies blast New York for 'clear course for failure' in state pot-business rollout

By Steve Gelsi Cannabis companies say New York's Office of Cannabis Management has 'ignored the collective wisdom of every other state' by not allowing existing medical-cannabis operators to expand into adult-use sales (MarketWatch)

September 05, 2023
Curaleaf Expands Brand Portfolio With Launch of Zero Proof ™ Cannabis-Infused Drinkables

Zero Proof's inaugural product offering, Squeeze, delivers fast-acting line of THC beverage enhancers in a sessionable and easy-to-use format Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international...(PR Newswire)

August 31, 2023
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

By Steve Gelsi Analysts praise the move but raise questions about the role of the FDA and how federal law will mesh with state programs The move by the Drug Enforcement Administration to review the Schedule I classification for...(MarketWatch)

August 30, 2023
HHS recommends rescheduling cannabis, and stocks in the sector rally

By Steve Gelsi Rescheduling to Schedule III from I would put cannabis in the same category as drugs with 'a moderate to low potential for physical and psychological dependence' (MarketWatch)

August 21, 2023
Curaleaf Celebrates Launch of Adult Use Sales at Manchester, CT Dispensary

Curaleaf Manchester is the Company's fourth dispensary in Connecticut to commence adult use sales Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today...(PR Newswire)

August 10, 2023
Canopy Growth beats analyst targets as its 'asset-light' strategy bears fruit, but Curaleaf's miss weighs on pot stocks

By Steve Gelsi Canada's Canopy Growth is launching a strategic review of its BioSteel business An earlier version of this story contained incorrect information about Canopy USA. (MarketWatch)

Curaleaf's Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

Select's new premium oil is formulated with liquified THCA "diamonds" and strain-specific cannabis-derived terpenes for an elevated experience Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international...(PR Newswire)

August 09, 2023
Curaleaf says it's trying to control costs, as big growth drivers remain elusive

U.S. multi-state cannabis producer Curaleaf Holdings Inc. on Wednesday reported a deeper-than-expected second-quarter loss and sales that were just short of expectations. Still, shares were up around 1% after hours. Curaleaf reported a net...(MarketWatch)

Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates

Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of -75% and 0.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?(Zacks)

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.